216 related articles for article (PubMed ID: 15457679)
1. Potential of 4'-C-substituted nucleosides for the treatment of HIV-1.
Hayakawa H; Kohgo S; Kitano K; Ashida N; Kodama E; Mitsuya H; Ohrui H
Antivir Chem Chemother; 2004 Jul; 15(4):169-87. PubMed ID: 15457679
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses.
Schinazi RF; Hernandez-Santiago BI; Hurwitz SJ
Antiviral Res; 2006 Sep; 71(2-3):322-34. PubMed ID: 16716415
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. D- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistance.
Wang J; Jin Y; Rapp KL; Schinazi RF; Chu CK
J Med Chem; 2007 Apr; 50(8):1828-39. PubMed ID: 17373782
[TBL] [Abstract][Full Text] [Related]
5. KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.
Harris KS; Brabant W; Styrchak S; Gall A; Daifuku R
Antiviral Res; 2005 Jul; 67(1):1-9. PubMed ID: 15890415
[TBL] [Abstract][Full Text] [Related]
6. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel 6',6'-difluoro 5'-deoxycarbocyclic phosphonic acid nucleosides as antiviral agents.
Kim E; Shen GH; Kang L; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2013; 32(7):396-410. PubMed ID: 23742064
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
Agarwal HK; Chhikara BS; Doncel GF; Parang K
Bioorg Med Chem Lett; 2017 May; 27(9):1934-1937. PubMed ID: 28351588
[TBL] [Abstract][Full Text] [Related]
9. The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population.
Pillay D
Antivir Ther; 2001; 6 Suppl 3():15-24. PubMed ID: 11678470
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
Elgemeie GE; Mansour OA; Metwally NH
Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
[TBL] [Abstract][Full Text] [Related]
11. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
Miller V; Larder BA
Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Anti-HIV Activity of Novel 2'-Deoxy-2'-β-Fluoro-Threosyl Nucleoside Phosphonic Acid Analogues.
Kim S; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2015; 34(12):815-33. PubMed ID: 26407633
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiviral evaluation of novel 2',2'-difluoro 5'-norcarbocyclic phosphonic acid nucleosides as antiviral agents.
Shen GH; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2014; 33(1):1-17. PubMed ID: 24588752
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 reverse transcriptase inhibitors.
El Safadi Y; Vivet-Boudou V; Marquet R
Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
[TBL] [Abstract][Full Text] [Related]
15. 4'-C-substituted-2'-deoxynucleosides: a family of antiretroviral agents which are potent against drug-resistant HIV variants.
Ohrui H; Mitsuya H
Curr Drug Targets Infect Disord; 2001 May; 1(1):1-10. PubMed ID: 12455229
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents.
Hamon N; Kaci M; Uttaro JP; Périgaud C; Mathé C
Eur J Med Chem; 2018 Apr; 150():642-654. PubMed ID: 29558735
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of 2'-fluoro-2',3'-unsaturated D-nucleosides as anti-HIV-1 agents.
Lee K; Choi Y; Gumina G; Zhou W; Schinazi RF; Chu CK
J Med Chem; 2002 Mar; 45(6):1313-20. PubMed ID: 11882000
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine.
Cihlar T; Ray AS
Antiviral Res; 2010 Jan; 85(1):39-58. PubMed ID: 19887088
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV evaluation of 3'-triazolo nucleosides.
Roy V; Obikhod A; Zhang HW; Coats SJ; Herman BD; Sluis-Cremer N; Agrofoglio LA; Schinazi RF
Nucleosides Nucleotides Nucleic Acids; 2011 Apr; 30(4):264-70. PubMed ID: 21623540
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of Human Immunodeficiency Virus type 1 (HIV-1) by a novel family of tricyclic nucleosides.
Bonache MC; Cordeiro A; Quesada E; Vanstreels E; Daelemans D; Camarasa MJ; Balzarini J; San-Félix A
Antiviral Res; 2011 Oct; 92(1):37-44. PubMed ID: 21600933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
